Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 114 (RNA5SP114) is a non-functional genomic sequence derived from a 5S ribosomal RNA gene. Pseudogenes like RNA5SP114 typically arise from gene duplication or retrotransposition events that become inactivated by mutations, leading to loss of rRNA coding capacity. While some pseudogenes may be transcribed, they generally do not encode functional RNAs or proteins and are not drug targets. Functional 5S rRNA forms part of the large ribosomal subunit critical for protein translation, but RNA5SP114 is a non-functional variant and does not contribute to ribosome biogenesis or function. Key points: - RNA5SP114 is a pseudogene, not a functional target or therapeutic molecule. - It is related to the 5S ribosomal RNA gene family but is non-functional due to accumulated mutations. - There is no current evidence of direct disease association, druggability, or biomarker utility for this specific pseudogene. - While some pseudogenes have emerging regulatory or biomarker roles in cancer, such roles have not been reported for RNA5SP114.
None applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 114 (RNA5SP114).